- ►nih.gov [PDF] LJ Black, M Sato, ER Rowley, DE Magee, … - Journal of Clinical …, 1994 - pubmedcentral.nih.gov There is a medical need for an agent with the positive effects of estrogen on bone and the cardiovascular
system, but without the negative effects on reproductive tissue. Raloxifene (LY139481 HCI) is
a benzothiophene derivative that binds to the estrogen receptor and inhibits the effects of ... Cited by 426 - Related articles - BL Direct - All 9 versions
- ►nih.gov [PDF] BL Riggs - Western Journal of Medicine, 1991 - pubmedcentral.nih.gov Epidemiology Osteoporosis is a major public health problem"2 In the United States, about 1.5
million fractures are attributable to osteoporosis each year. The sites of these fractures are the
vertebrae (650,000), the hip (250,000), the distal fore- arm (Colles' fracture, 200,000), and ... Cited by 143 - Related articles - All 5 versions
KF McFarland, ME Boniface, CA Hornung, W Earnhardt … - American heart journal, 1989 - Elsevier To evaluate the risk factors for coronary disease, 345 women, aged 35 to 59 years, who had
undergone coronary arteriography for suspected coronary disease completed a mall
questionnaire, telephone interview, or both. Two hundred eight women with ... Cited by 143 - Related articles - All 3 versions
- ►ahajournals.org GA Figtree, Y Lu, CM Webb, P Collins - Circulation, 1999 - Am Heart Assoc Methods and Results—–Rings of coronary artery from adult male and nonpregnant female New
Zealand White rabbits were suspended in organ baths containing Krebs solution; isometric tension
was then measured. Raloxifene induced coronary arterial relaxation in male and female ... Cited by 119 - Related articles - BL Direct - All 6 versions
C Schairer, HO Adami, R Hoover, I Persson - Epidemiology, 1997 - jstor.org Catherine Schairer,1 Hans-Olov Adami,2 Robert Hoover,1 and Ingemar Persson2'3 ... To assess
the risks and benefits of menopausal hormone re- placement therapy, we followed a
23,246-member, population- based cohort of Swedish women who were prescribed meno- Cited by 100 - Related articles - BL Direct - All 5 versions
- ►peralta.edu [PDF] GL Burke, C Legault, M Anthony, DR Bland, TM … - Menopause, 2003 - journals.lww.com Gregory L. Burke, MD, MSc,1 Claudine Legault, PhD,1 Mary Anthony, MS,1,2 Deirdre R.
Bland, MD,3 Timothy M. Morgan, PhD,1 Michelle J. Naughton, PhD,1 Kelly Leggett, MD,1 Scott
A. Washburn, MD,4 and Mara Z. Vitolins, DrPH1 ... ABSTRACT Objective: To investigate ... Cited by 84 - Related articles - BL Direct - All 6 versions
PD Wilson, B Faragher, B Butler, D Bu' … - … Journal of Obstetrics …, 1987 - interscience.wiley.com The use of oestrogens in the treatment of genuine stress incontinence was assessed by a
double-blind prospective trial in 36 postmenopausal women with genuine stress incontinence
who received 3 months of cyclical treatment with either piperazine oestrone sulphate or a ... Cited by 82 - Related articles - All 4 versions
BH Arjmandi, BJ Smith - The Journal of Nutritional Biochemistry, 2002 - Elsevier Ovarian hormone deficiency is a major risk factor for osteoporosis. Current therapies emphasize
the use of antiresorptive agents, such as estrogen, calcitonin, and bisphosphonates. These therapies
are associated with certain risks and side effects making compliance a major obstacle. ... Cited by 79 - Related articles - BL Direct - All 9 versions
E Anne MacGregor - Lancet Neurology, 2004 - Elsevier During women's reproductive years, migraine is three times more common than in men of a similar
age. Although this female preponderance is commonly assumed to be associated with the additional
trigger of fluctuating sex hormones of the menstrual cycle, few studies have been done to ... Cited by 60 - Related articles - All 2 versions
